Transvenous lead performance of implantable cardioverter‐defibrillators and pacemakers
Background After the reports of recalled leads, several technological improvements have been introduced and the durability of implantable cardioverter defibrillator (ICD) leads has improved. The incidence of lead failures is now less than in the previous studies. However, there are few reports that...
Gespeichert in:
Veröffentlicht in: | Pacing and clinical electrophysiology 2021-03, Vol.44 (3), p.481-489 |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Background
After the reports of recalled leads, several technological improvements have been introduced and the durability of implantable cardioverter defibrillator (ICD) leads has improved. The incidence of lead failures is now less than in the previous studies. However, there are few reports that have shown the long‐term durability of ICD leads as compared to pacemaker (PM) leads. This study analyzed the medium to long‐term performance of transvenous ICD leads as compared to PM leads.
Methods
We retrospectively studied 1227 cases from April 2007 to December 2017 who underwent an initial transvenous ICD or PM implantation. The number of lead failures and patient background characteristics were analyzed.
Results
During a median 3–3.5 years follow up period, 1 (0.3%) ICD lead and 18 (2.4%) PM leads failed. The incidence of lead failures was significantly higher in the PM group than ICD group (p = .019). Males were associated with a higher incidence of lead failures in the PM group.
Conclusion
Since the era of recalled ICD leads, the durability of ICD leads has remarkably improved and the incidence of lead failures with non‐recalled ICD leads has been less than that for PM leads. |
---|---|
ISSN: | 0147-8389 1540-8159 |
DOI: | 10.1111/pace.14154 |